Growing problem of multidrug-resistant enteric pathogens in Africa

Emerging Infectious Diseases

Volumn 13, Issue 11, 2007, Pages 1640-1646

  Okeke, Iruka N ^a   Aboderin, Oladiipo A ^b   Byarugaba, Denis K ^c   Ojo, Kayode K ^d   Opintan, Japheth A ^e  

^a HAVERFORD COLLEGE   (United States)

^b OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

^c MAKERERE UNIVERSITY   (Uganda)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF GHANA   (Ghana)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; AMPICILLIN; ANTIINFECTIVE AGENT; COTRIMOXAZOLE; ERYTHROMYCIN; QUINOLONE DERIVATIVE; TETRACYCLINE;

AFRICA; CHOLERA; DIARRHEA; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPIDEMIC; ESCHERICHIA COLI; GASTROENTERITIS; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION CONTROL; MALARIA; MORTALITY; MULTIDRUG RESISTANCE; PREVALENCE; PROPHYLAXIS; QUALITY CONTROL; RESPIRATORY TRACT INFECTION; REVIEW; SALMONELLA ENTERITIDIS; TUBERCULOSIS; VIBRIO CHOLERAE;

EID: 36248982787     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1311.070674     Document Type: Review

References (41)

1. Bates I, Fenton C, Gruber J, Lalloo D, Medina Lara A, Squire SB, Theobald S. Vulnerability to malaria, tuberculosis, and HIV/AIDS infection and disease. Part 1: determinants operating at individual and household level. Lancet Infect Dis. 2004;4:267-77.
2. Schellenberg JA, Victora CG, Mushi A, de Savigny D, Schellenberg D, Mshinda H, et al. Inequities among the very poor: health care for children in rural southern Tanzania. Lancet. 2003;361:561-6.
3. Arrow K, Panosian C, Gelband H. Saving lives, buying time. Economics of malaria drugs in an age of resistance. Washington: National Academies Press; 2004.
4. Singh JA, Upshur R, Padayatchi N. XDR-TB in South Africa: no time for denial or complacency. PLoS Med. 2007;4:e50.
5. Griffith DC, Kelly-Hope LA, Miller MA. Review of reported cholera outbreaks worldwide, 1995-2005. Am J Trop Med Hyg. 2006;75:973-7.
6. Merrell DS, Butler SM, Qadri F, Dolganov NA, Alam A, Cohen MB, et al. Host-induced epidemic spread of the cholera bacterium. Nature. 2002;417:642-5.
7. Towner KJ, Pearson NJ, Mhalu FS, O'Grady F. Resistance to antimicrobial agents of Vibrio cholerae E1 Tor strains isolated during the fourth cholera epidemic in the United Republic of Tanzania. Bull World Health Organ. 1980;58:747-51.
8. Finch MJ, Morris JG Jr, Kaviti J, Kagwanja W, Levine MM. Epidemiology of antimicrobial resistant cholera in Kenya and East Africa. Am J Trop Med Hyg. 1988;39:484-90.
9. Mwansa JC, Mwaba J, Lukwesa C, Bhuiyan NA, Ansaruzamman M, Ramamurthy T, et al. Multiply antibiotic-resistant Vibrio cholerae O1 biotype El Tor strains emerge during cholera outbreaks in Zambia. Epidemiol Infect. 2007;135:847-53.
10. Ceccarelli D, Salvia AM, Sami J, Cappuccinelli P, Colombo MM. new cluster of plasmid-located class 1 integrons in Vibrio cholerae O1 and a dfrA15 cassette-containing integron in Vibrio parahaemolyticus isolated in Angola. Antimicrob Agents Chemother. 2006;50:2493-9.
11. Siddique AK, Salam A, Islam MS, Akram K, Majumdar RN, Zaman K, et al. Why treatment centres failed to prevent cholera deaths among Rwandan refugees in Goma, Zaire. Lancet. 1995;345:359-61.
12. Dalsgaard A, Forslund A, Petersen A, Brown DJ, Dias F, Monteiro S, et al. Class 1 integron-borne, multiple-antibiotic resistance encoded by a 150-kilobase conjugative plasmid in epidemic Vibrio cholerae O1 strains isolated in Guinea-Bissau. J Clin Microbiol. 2000;38:3774-9.
13. Cooke FJ, Wain J. The emergence of antibiotic resistance in typhoid fever. Travel Med Infect Dis. 2004;2:67-74.
14. Kariuki S, Revathi G, Kariuki N, Kiiru J, Mwituria J, Hart CA. Characterisation of community acquired non-typhoidal Salmonella from bacteraemia and diarrhoeal infections in children admitted to hospital in Nairobi, Kenya. BMC Microbiol. 2006;6:101.
15. Berkley JA, Lowe BS, Mwangi I, Williams T, Bauni E, Mwarumba S, et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med. 2005;352:39-47.
16. Vila J, Vargas M, Casals C, Urassa H, Mshinda H, Schellemberg D, et al. Antimicrobial resistance of diarrheagenic Escherichia coli isolated from children under the age of 5 years from Ifakara, Tanzania. Antimicrob Agents Chemother. 1999;43:3022-4.
17. Okeke IN, Lamikanra A, Czeczulin J, Dubovsky F, Kaper JB, Nataro JP. Heterogeneous virulence of enteroaggregative Escherchia coli strains isolated from children in Southwest Nigeria. J Infect Dis. 2000;181:252-60.
18. Presterl E, Zwick RH, Reichmann S, Aichelburg, A, Winkler, S, Kremsner, PG, Graninger W. Frequency and virulence properties of diarrheagenic Escherichia coli in children with diarrhea in Gabon. Am J Trop Med Hyg. 2003;69:406-10.
19. Senerwa D, Olsvik O, Mutanda LN, Lindqvist, KJ, Gathuma, JM, Fossum, K, Wachsmuth K. Enteropathogenic Escherichia coli serotype O111:HNT isolated from preterm neonates in Nairobi, Kenya. J Clin Microbiol. 1989;27:1307-11.
20. Okeke IN, Nataro JP. Enteroaggregative Escherichia coli. Lancet Infect Dis. 2001;1:304-13.
21. Gassama A, Sow PS, Fall F, Camara P, Gueye-N'diaye A, Seng R, et al. Ordinary and opportunistic enteropathogens associated with diarrhea in Senegalese adults in relation to human immunodeficiency virus serostatus. Int J Infect Dis. 2001;5:192-8.
22. Okeke IN, Fayinka ST, Lamikanra A. Antibiotic resistance in Escherichia coli from Nigerian students, 1986-1998. Emerg Infect Dis. 2000;6:393-6.
23. Nys S, Okeke IN, Kariuki S, Dinant GJ, Driessen C, Stobberingh EE. Antibiotic resistance of faecal Escherichia coli from healthy volunteers from eight developing countries. J Antimicrob Chemother. 2004;54:952-5.
24. Lamikanra A, Okeke IN. A study of the effect of the urban/rural divide on the incidence of antibiotic resistance in Escherichia coli. Biomed Lett. 1997;55:91-7.
25. Okeke IN, Edelman R. Dissemination of antibiotic-resistant bacteria across geographic borders. Clin Infect Dis. 2001;33:364-9.
26. Roper C, Pearce R, Nair S, Sharp B, Nosten F, Anderson T. Intercontinental spread of pyrimethamine-resistant malaria. Science. 2004;305:1124.
27. Guerrant RL, Oria R, Bushen OY, Patrick PD, Houpt E, Lima AA. Global impact of diarrheal diseases that are sampled by travelers: the rest of the hippopotamus. Clin Infect Dis. 2005;41(Suppl 8):S524-30.
28. Tumwine JK. Clean drinking water for homes in Africa and other less developed countries. BMJ. 2005;331:468-9.
29. Laxminarayan R, Bhutta Z, Duse A, Jenkins P, O'Brien T, Okeke IN, et al. Drug resistance. In: Jamison D, Breman JG, Measham AR, Alleyane G, Claeson M, Evans DB, et al., editors. Disease control priorities in developing countries. New York: Oxford University Press; 2006. p. 1031-51.
30. World Health Organization (WHO). WHO global strategy for containment of antibiotic resistance. Geneva: The Organization; 2001. p. 99.
31. Mainous AG III, Hueston WJ, Davis MP, Pearson WS. Trends in antimicrobial prescribing for bronchitis and upper respiratory infections among adults and children. Am J Public Health. 2003;93:1910-4.
32. Aarestrup FM, Seyfarth AM, Emborg H-D, Pedersen K, Hendriksen RS, Bager F. Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark. Antimicrob Agents Chemother. 2001;45:2054-9.
33. World Health Organization (WHO). Counterfeit medicines: an update on estimates. Geneva: WHO International Medical Products Anti-Counterfeiting Task Force; 2006.
34. Shakoor O, Taylor RB, Behrens RH. Assessment of the incidence of substandard drugs in developing countries. Trop Med Int Health. 1997;2:839-45.
35. Okeke IN, Klugman KP, Bhutta ZA, Duse AG, Jenkins P, O'Brien TF, et al. Antimicrobial resistance in developing countries. Part II: strategies for containment. Lancet Infect Dis. 2005;5:568-80.
36. Victora CG, Huicho L, Amaral JJ, Armstrong-Schellenberg J, Manzi F, Mason E, et al. Are health interventions implemented where they are most needed? District uptake of the integrated management of childhood illness strategy in Brazil, Peru and the United Republic of Tanzania. Bull World Health Organ. 2006;84:792-801.
37. Byarugaba DK. A view on antimicrobial resistance in developing countries and responsible risk factors. Int J Antimicrob Agents. 2004;24:105-10.
38. Petti CA, Polage CR, Quinn TC, Ronald AR, Sande MA. Laboratory medicine in Africa: a barrier to effective health care. Clin Infect Dis. 2006;42:377-82.
39. Okeke IN. Diagnostic insufficiency in Africa. Clin Infect Dis. 2006;42:1501-3.
40. Canton R, Morosini M, Enright MC, Morrissey I. Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae: data from the global PROTEKT surveillance programme. J Antimicrob Chemother. 2003;52:944-52. Epub 2003 Oct 29.
41. O'Brien TF, Stelling JM. WHONET: removing obstacles to the full use of information about antibiotic resistance. Diagn Microbiol Infect Dis. 1996;25:162-8.